Do topical calcineurin inhibitors treat ashy dermatosis?

Ashy dermatosis causes grey-brown or blue-grey patches that can resemble other pigment conditions. A topical calcineurin inhibitor changes local immune signalling and can calm inflammation without the same skin-thinning effect associated with prolonged topical steroid use. Its benefit for colour change is not uniform: the medicine may settle active inflammation, while existing pigment can take longer to fade or may remain. The appearance, distribution, symptoms and any recent medicines or irritants help guide the diagnosis.

Arrange a dermatology assessment before applying this medicine to widespread or unexplained patches. If prescribed, apply a thin layer only to the affected skin and follow the clinician’s schedule. Temporary warmth or stinging can occur after application. Use gentle cleansing, moisturiser and sun protection to reduce irritation and make colour differences less noticeable. Do not place the medicine on infected, crusted or open skin unless your clinician specifically directs you.

Seek prompt medical advice if patches spread quickly, become painful, ooze, crust or develop marked swelling. Arrange review if burning persists, the skin becomes increasingly irritated, or there is no clear improvement after the agreed treatment period. New pigment change after starting a medicine or exposure to a chemical also deserves assessment, because the cause may need a different approach.

Ask whether the pattern fits ashy dermatosis, whether inflammation is active, how long to try the medicine, and what symptoms should prompt a review. Clarify whether you should continue moisturiser and sun protection, and whether another diagnosis would change the treatment.